Bioethics Blogs

Funding Medical Innovation

In a recent National Affairs essay titled “Removing Barriers to Medical Innovation,” Thomas Stossel, Professor of Medicine at Harvard Medical School, cautions against “pharmaphobia,” a term he has coined for the widespread vilification of the private pharmaceutical industry. Stossel, a visiting scholar at the American Enterprise Institute, has written lengthily on the subject, most notably in his book titled Pharmaphobia: How the Conflict of Interest… // Read More »

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.